Source: Issels Blog

Issels Blog Research: New Blood Test ID’s Breast Cancer Patients Who May Relapse

In addition to fighting primary tumors, immunotherapy for cancer aims to prevent future recurrence. Scientists recently made a major breakthrough with the discovery of an indicator of possible relapse in patients with HR-positive breast cancer. Searching for Clues to Breast Cancer Recurrence Breast cancer treatment has improved significantly, but unfortunately many women are subject to … Continue reading Research: New Blood Test ID’s Breast Cancer Patients Who May Relapse →

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Christian N. Issels's photo - CEO of Issels

CEO

Christian N. Issels

CEO Approval Rating

81/100